16. Meng F., Xie G. X., Thompson R. C., Mansour A., Goldstein A., Watson S. J. and Akil H. (1993) Cloning and
pharmacological characterization of a rat kappa opioid receptor. Proc. natn. Acad. Sci. U.S.A. 90, 9954–9958.
17. Millhorn D. E., Hokfelt T., Seroogy K., Oertel W., Verhofstad A. A. and Wu J. Y. (1987) Immunohistochemical
evidence for colocalization of gamma-aminobutyric acid and serotonin in neurons of the ventral medulla oblongata
projecting to the spinal cord. Brain Res. 410, 179–185.
18. Millhorn D. E., Hokfelt T., Seroogy K. and Verhofstad A. A. (1988) Extent of colocalization of serotonin and GABA
in neurons of the ventral medulla oblongata in rat. Brain Res. 461, 169–174.
19. Minami M., Toya T., Katao Y., Maekawa K., Nakamura S., Onogi T., Kaneko S. and Satoh M. (1993) Cloning and
expression of a cDNA for the rat kappa-opioid receptor. Fedn Eur. biochem. Socs Lett. 329, 291–295.
20. Monroe P. J., Kradel B. K., Smith D. L. and Smith D. J. (1995) Opioid eVects on spinal [3H]5-hydroxytryptamine
release are not related to their antinociceptive action. Eur. J. Pharmac. 272, 51–56.
21. Mugnaini E. and Oertel W. H. (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS
as revealed by GAD immunohistochemistry. In Handbook of Chemical Neuroanatomy (eds Bjorklund A. and Ho ̈ kfelt
T.), Vol. 4, pp. 436–608. Elsevier, Amsterdam.
22. Nishi M., Takeshima H., Fukuda K., Kato S. and Mori K. (1993) cDNA cloning and pharmacological characterization of an opioid receptor with high aYnities for kappa-subtype-selective ligands. Fedn Eur. biochem. Socs Lett. 330,
77–80.
23. Pan Z. Z., Tershner S. A. and Fields H. L. (1997) Cellular mechanism for anti-analgesic action of agonists of the
kappa-opioid receptor. Nature 389, 382–385.
24. Pan Z. Z., Wessendorf M. W. and Williams J. T. (1993) Modulation by serotonin of the neurons in rat nucleus raphe
magnus in vitro. Neuroscience 54, 421–429.
25. Pinnock R. D. (1992) A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials
in the rat locus coeruleus in vitro. Neuroscience 47, 87–94.
26. Schmued L. C. and Fallon J. H. (1986) Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique
properties. Brain Res. 377, 147–154.
27. Skageberg G. and Bjorklund A. (1985) Topographic principles in the spinal projections of serotonergic and
non-serotonergic brainstem neurons in the rat. Neuroscience 15, 445–480.
28. Steinbusch H. W. (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat—cell
bodies and terminals. Neuroscience 6, 557–618.
29. Tempel A. and Zukin R. S. (1987) Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain
as determined by quantitative in vitro autoradiography. Proc. natn. Acad. Sci. U.S.A. 84, 4308–4312.
30. Vonvoigtlander P. F., Lewis R. A. and NeV G. L. (1984) Kappa opioid analgesia is dependent on serotonergic
mechanisms. J. Pharmac. exp. Ther. 231, 270–274.
31. Wessendorf M. W. (1991) Fluoro-Gold: composition, and mechanism of uptake. Brain Res. 553, 135–148.
32. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T. and Bell G. I. (1993) Cloning and functional
comparison of kappa and delta opioid receptors from mouse brain. Proc. natn. Acad. Sci. U.S.A. 90, 6736–6740.
